AbCellera Biologics Inc. Liquidation Value
ABCL
Other
Cash & Equivalents
$128.51M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $128.51M
Total Obligations: -$207.53M
$-79.01M
Per share: $-0.26
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $128.51M
AR: $39.41M
Total Obligations: -$207.53M
$-39.60M
Per share: $-0.13
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $128.51M
AR: $39.41M
Inventory: $6.34M
Total Obligations: -$207.53M
$-33.26M
Per share: $-0.11
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-79.01M | $-0.26 |
| Liquid Liquidation Value | $-39.60M | $-0.13 |
| Operating Liquidation Value | $-33.26M | $-0.11 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $128.51M |
| Accounts Receivable | $39.41M |
| Inventory | $6.34M |
| Current Liabilities | $64.31M |
| Long-term Debt | N/A |
| Op. Lease Liability | $143.22M |
| Finance Lease | N/A |
| Shares Outstanding | 300.6M |
Explore all 156 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $128.51M | $39.41M | $6.34M | N/A | $64.31M | N/A | $143.22M | N/A |
| 2025-09-30 | $83.16M | $71.25M | N/A | N/A | $68.80M | N/A | $142.22M | N/A |
| 2025-06-30 | $92.44M | $70.00M | N/A | N/A | $67.02M | N/A | $142.08M | N/A |
| 2025-03-31 | $159.27M | $63.61M | N/A | N/A | $75.40M | N/A | $67.85M | N/A |
▼ Community Notes